Patent · US Active

PAR2 mimetic peptides and uses thereof

US11351264B2 · kind B2 · utility

0Cited by

0References

6Claims

0Family size

Assignees

Arizona Board of Regents on Behalf of the University of Arizona · US
The Board of Regents of the University of Texas System · US

Inventors

Scott A. Boitano · Tucson, US
Josef Vagner · Tucson, US
Theodore J. Price · Austin, US

Key dates

Filing date	Mar 31, 2017
Grant date	Jun 7, 2022
Priority date	—
Expiry date	Jul 10, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention is in the field of medicinal pharmacology. In particular, the invention relates to protease activated receptor type 2 (PAR2) modulating compounds (e.g., mimetic peptides), compositions comprising such modulating compounds, and their use as therapeutics for the treatment of conditions involving PAR2 activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.